Industry and Consumer Advocates Square Off on Social Media
This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board.
Industry and Consumer Advocates Square Off Regarding Social Media
This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board.
Pharma Marketing News Vol. 9, #3: March 2010
Welcome to the MARCH 2010 issue of Pharma Marketing News.
Pharma Marketing News Vol. 9, #3: March 2010
Welcome to the MARCH 2010 issue of Pharma Marketing News.
Pfizer’s Bait and Switch Facebook Pfan Strategy
Yesterday afternoon at approximately 3 PM ET, @pfizer_news posted this tweet: "Become a Fan of Pfizers official page on Facebook: http://bit.ly/aGX49f" About an hour...
If Drugs Were Like Automobiles
According to an Institute for Safe Medication Practices report (see here) more than 1000 reports of patient deaths were received by FDA for rosiglitazone...
Will FDA’s SM Guidance Resemble Suggestions Made by Industry Group Back in October?
Yesterday, during a Pharma Marketing Talk live podcast/interview, Cynthia Phillips, who is currently Senior Director of Regulatory Labeling and Promotional Compliance at Millennium Pharmaceuticals,...
Geez, GSK! Find Another Source of “Balanced” Commentary
GSK continues to use its "More Than Medicine" blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see...
Steve Nissen to GSK (and FDA): “Put Patients First! It’s Time to Pull Avandia...
Internal FDA reports -- part of a fierce debate within the agency over what to do about GSK's Avandia -- obtained by the New...
“An Eye on Big Pharma”: I am Feautured in NYIT Magazine Article
I received an MA degree in Communication Arts from the New York Institute of Technology in 1988. The school's PR person somehow got wind...
